Key result
High-intensity warfarin self-testing via an e-Health platform modestly improved time in therapeutic range compared with usual care (MD 5.65%).
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ritchie et al. (2022) conducted an editorial in Warfarin anticoagulation (n=5,895). Warfarin self-testing via e-Health platform (PST/High/e-Health) vs. Usual care was evaluated on Time in therapeutic range (TTR) (MD 5.65%, 95% CI 0.04-11.26). High-intensity warfarin self-testing via an e-Health platform modestly improved time in therapeutic range compared with usual care (MD 5.65%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: